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Introduction
Mitochondria of healthy cells continually divide and fuse with 
each other (Hoppins et al., 2007). The balance between fission 
and fusion is controlled by the opposing actions of several 
large GTP-binding proteins, which are members of the dynamin   
family. DRP1 in mammals and Dnm1 in yeast mediate mito-
chondrial  fission  by  wrapping  around  constricted  parts  of 
mitochondria, where they control a late stage of the fission process 
(Hoppins et al., 2007). Mitochondrial fusion is mediated by 
dynamin-related proteins in the outer (mitofusins in mammals 
and Fzo1 in yeast) and inner membrane (OPA1 in mammals 
and Mgm1 in yeast; Olichon et al., 2003; Wong et al., 2003).   
Mitochondrial fission and fusion proteins have antagonistic func-
tions during apoptosis. Mutations in Drp1 inhibit cytochrome c 
release during apoptosis, suggesting that fission proteins are 
proapoptotic (Frank et al., 2001), whereas loss of OPA1 promotes 
cytochrome c release, suggesting that OPA1 is antiapoptotic 
(Olichon et al., 2003). OPA1 is intensely studied because of this 
connection with apoptosis and because mutations in OPA1 are 
the most prevalent cause of dominant optic atrophy (DOA), a 
progressive eye disease which affects retinal ganglion cells in 
the optic nerve.
OPA1 functions are controlled by complex patterns of   
alternative splicing and proteolysis. Humans have eight different 
isoforms, which all have a mitochondrial leader sequence that 
is cleaved by the mitochondrial matrix protease (mitochondrial 
processing peptidase) upon import into mitochondria. In yeast, 
roughly half of the protein is further cleaved by a rhomboid pro-
tease, but in mammals, the situation is less clear. It was reported 
that mammalian OPA1 is also cleaved by a rhomboid protease 
(Cipolat et al., 2006), but knockout cells show no differences 
in OPA1 processing (Griparic et al., 2007). Additionally, it was 
reported that OPA1 is cleaved by the mitochondrial matrix pro-
tease paraplegin, but the effects of paraplegin siRNA were, at 
best, modest (Ishihara et al., 2006). Some confusion may have 
arisen from the fact that OPA1 processing follows two distinct 
paths. OPA1 isoforms containing alternatively spliced exons 
4b or 5b are constitutively cleaved by the intermembrane space 
AAA (ATPase associated with diverse cellular activities) pro-
tease YME1L, generating the short form of OPA1 (S-OPA1), 
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represents a novel regulatory mechanism that will likely affect 
mitochondrial turnover, apoptosis, and the progression of neuro-
degenerative diseases such as DOA.
Results and discussion
OMA1 is a mitochondrial protein affected 
by membrane potential
Human OMA1 is similar in sequence to the yeast mitochondrial 
inner membrane protease Oma1 (Kaser et al., 2003). However, 
human OMA1 has been localized to the ER (Bao et al., 2003). 
This discrepancy prompted us to reinvestigate the localization 
of human OMA1 using an expression construct with full-length 
OMA1 and two C-terminal HA tags (subsequent experiments show 
that this fusion protein is functional). Transfection of this con-
struct into HeLa cells showed colocalization with MitoTracker 
(Fig. 1 A), whereas differential centrifugation showed cofrac-
tionation with mitochondrial markers but not with ER or cyto-
solic markers (Fig. 1 B). We conclude that human OMA1 is a 
mitochondrial protein.
Transfections with OMA1 constructs consistently yielded a 
band of 40 kD (Fig. 1 B), whereas the predicted size of OMA1 
is 62 kD. Even if OMA1 had a cleaved targeting sequence, we 
would have expected a protein of at least 55 kD. Instead, OMA1 
is cleaved further into the N-terminal half of the protein (the 
product was detected with C-terminal tags). Transfections with 
YME1L, AFG3L2, and paraplegin siRNA had no effect on 
OMA1 cleavage, but there may still have been residual prote-
ases in these experiments (unpublished data). At this point, it is 
still not known which protease cleaves OMA1. However, we did 
notice differences in OMA1 banding patterns when membrane 
potential was dissipated with CCCP. Transfections with two dif-
ferent constructs (one wild type and one with a point mutation in 
the zinc-binding motif) showed that the amount of 40-kD protein 
decreased and a 60-kD protein appeared when cells were treated 
with CCCP (Fig. 2 A). Rapid appearance of a 60-kD protein sug-
gests that OMA1 continues to be synthesized and imported into 
mitochondria, which is similar to the CCCP-resistant import 
of several other mitochondrial proteins such as cytochrome b2 
(Geissler et al., 2000). The newly formed 60-kD band co- 
migrated with in vitro–synthesized OMA1 protein (Fig. 2 B), 
suggesting that OMA1 does not have a cleaved mitochondrial 
leader sequence. High levels of 40-kD protein in untreated cells 
and its replacement by uncleaved protein after treatment with 
CCCP suggest that full-length OMA1 is cleaved at a high rate 
and that this cleavage is inhibited by treatment with CCCP.
To further investigate OMA1 processing, we conducted in   
vitro import experiments with OMA1 protein and isolated mito-
chondria. Su9–dihydrofolate reductase (DHFR) fusion protein, 
which is targeted to the mitochondrial matrix, served as a 
control. Su9-DHFR precursor protein was observed in the 
mitochondrial pellet, but this protein was removed with trypsin 
digestion, whereas the mature Su9-DHFR, as detected by cleav-
age of the mitochondrial leader sequences, was trypsin insensi-
tive (Fig. 2 C). When mitochondria were incubated with OMA1 
protein, they contained 40- and 60-kD proteins similar to those 
observed in vivo. The 40-kD protein was trypsin insensitive, 
whereas the remaining isoforms are normally not cleaved further, 
generating the long form of OPA1 (L-OPA1; Griparic et al., 
2007; Song et al., 2007). S- and L-OPA1 are both required for 
fusion, so constitutive cleavage is needed for a functional fusion 
apparatus (Song et al., 2007; DeVay et al., 2009).
L-OPA1 isoforms do remain susceptible to cleavage by a 
different, inducible protease (Griparic et al., 2007). Inducible 
cleavage  is  triggered  by  loss  of  mitochondrial  membrane   
potential, by ATP deficiency, and by apoptosis (Baricault et al.,   
2007; Griparic et al., 2007). This cleavage is rapid and com-
plete, fully inactivating the remaining population of uncleaved 
OPA1  molecules.  Loss  of  membrane  potential  caused  by 
the protonophore carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP) blocks mitochondrial fusion by inactivating OPA1. 
Mitochondria can reestablish a filamentous morphology after 
regaining membrane potential (CCCP washout), but this recov-
ery requires de novo synthesis of OPA1 (Griparic et al., 2007). 
We now show that inducible proteolysis is mediated by OMA1, 
a protease with multiple membrane-spanning segments and a 
zinc-binding motif. Inducible proteolysis mediated by OMA1 
Figure 1.  Localization of OMA1 to mitochondria in human cells. (A) HeLa 
cells  were  transfected  with  OMA1-HA  and  stained  with  HA  antibody   
(left; green) and MitoTracker (middle; red). A merged image is shown on the 
right. Only one transfected cell is shown here, but many other transfected 
cells were observed, invariably showing colocalization of OMA1-HA and 
MitoTracker. The insets show enlargements to display the colocalization of 
HA antibody and MitoTracker staining more clearly. (B) Subcellular frac-
tionation of OMA1-HA–transfected HeLa cells showing volume equivalents 
of postnuclear supernatant (lane 1), medium speed supernatant (lane 2), 
and medium speed pellet (lane 3) blotted and probed with HA, mitochon-
drial (COXI), and ER (calnexin) antibodies. Bar, 10 µm.961 Inducible cleavage of OPA1 by OMA1 • Head et al.
We used carbonate extractions to distinguish proteins that 
are genuinely inserted into membrane from peripherally bound 
or soluble proteins. As expected, mature Su9-DHFR was released 
showing that this protein is imported, whereas the 60-kD band 
was degraded, similar to the SU9-DHFR precursor, suggesting 
that the 60-kD protein remains accessible to trypsin (Fig. 2 C).
Figure 2.  Changes in the cleavage of OMA1 upon treatment with CCCP and oligomycin. (A) HeLa cells were transfected with wild-type (wt) OMA1 or 
OMA1(H331A) mutant constructs. Treatment for 30 min with CCCP decreases the intensity of the 40-kD band, and a previously undetectable 60-kD protein 
appears. (B) Comparison between in vitro–synthesized OMA1 and the 60-kD band in OMA1-transfected and CCCP-treated HeLa cells. Unlabeled cell 
extract was added to radiolabeled OMA1 to load similar amounts of protein in different lanes. (A and B) Black lines indicate that intervening lanes have 
been spliced out. (C–F) Import of in vitro–synthesized OMA1 into isolated mitochondria. (C) Mitochondria were incubated with OMA1 or Su9-DHFR for 
20 min. (D) Carbonate supernatants are shown for a Su9-DHFR time course with a 20-min carbonate (carb.) pellet as control. (E and F) Carbonate pellets 
are shown for an OMA1 time course with a 20-min supernatant as control. (F) Oligomycin and bongkrekic acid were added to the reactions to reduce 
mitochondrial ATP. IN, input lanes showing 10% of OMA1 in import reactions; m, mature protein; p, Su9-DHFR precursor; O/B, oligomycin and bongkrekic 
acid; Trp, trypsin; V/C, valinomycin and CCCP.JCB • VOLUME 187 • NUMBER 7 • 2009   962
obvious effect on steady-state levels of mitochondrial connectivity, 
but there were some localized swellings, which could be caused 
by another as of yet unknown function of OMA1 (Fig. S2, 
D and D).
We further tested the role of OMA1 in inducible cleavage 
with a rescue experiment in which OMA1 siRNA–transfected 
cells were cotransfected with wild-type or mutant (H331A) 
OMA1  constructs. Transfection  with  either  construct  did  not 
change mitochondrial morphology in wild-type cells (Fig. S2 A)   
nor did it cause more cleavage of OPA1 (Fig. 3 B), perhaps because 
OMA1 is rapidly degraded without CCCP. Nevertheless, wild-
type OMA1 was able to compensate for OMA1 siRNA by restor-
ing CCCP-induced cleavage of OPA1, whereas OMA1(H331A) 
did not restore cleavage (Fig. 3 B). The differences were statisti-
cally significant, as shown by densitometry of Western blots from 
three independent experiments (mean of 23% in band b [SD = 
10.5; n = 3] with OMA1 siRNA, wild-type OMA1, and CCCP; 
mean of 55% in band b [SD = 6.1; n = 3] with OMA1 siRNA, 
OMA1(H331A), and CCCP; P = 0.010 in an unpaired Student’s 
t test). Together, these experiment show that OMA1 mediates 
inducible cleavage of OPA1 and that this cleavage depends on 
intact protease sequences. In addition, we observed changes in 
OMA1 bands upon treatment with CCCP, confirming that these 
changes correspond with changes in OMA1 function.
To determine which cleavage sites are affected by OMA1, 
we transfected HeLa cells with expression constructs encoding 
three representative OPA1 isoforms with different cleavage sites 
(isoforms 1, 5, and 7; Griparic et al., 2007). These constructs 
were cotransfected with OMA1 or YME1L siRNA followed by 
CCCP treatment to compare constitutive with induced cleavage. 
Isoform 1 has only one cleavage site (S1 in exon 5), which is 
not cleaved by YME1L but is cleaved by the inducible protease 
(Griparic et al., 2007). Our results show that isoform 1 cleavage 
was induced by CCCP but not in cells transfected with OMA1 
siRNA (Fig. 3 B). Isoforms 5 and 7 are constitutively cleaved 
by YME1L in exons 4b and 5b, respectively (Griparic et al., 
2007). This was confirmed in this study with YME1L siRNA   
(Fig. S1 B). These isoforms became susceptible to CCCP-
induced cleavage upon transfection with YME1L siRNA (Fig. 3 
and Fig. S1 B). We conclude that OMA1 cleaves OPA1 in the 
S1 site (exon 5), which is present in all three isoforms, but iso-
forms 5 and 7 are only cleaved by OMA1 when constitutive 
cleavage in exons 4b and 5b is prevented with YME1L siRNA 
(Fig. S1 B).
Effects of OMA1 siRNA on mitochondrial 
fusion after CCCP washout
The effects of OMA1 on mitochondrial fusion were tested by 
transfecting cells with OMA1 siRNA, fragmenting their mito-
chondria with CCCP and monitoring recovery of filamentous 
mitochondria through fusion after CCCP washout. Fragmenta-
tion still occurred in OMA1 siRNA cells (Fig. 3 G) because 
fragmentation is mediated by DRP1 (Griparic et al., 2007), but 
these cells recovered tubular mitochondrial morphologies more 
quickly than cells transfected with scrambled siRNA (Fig. 3,   
E and H). The differences were most pronounced at 60 and 
90 min after CCCP washout (Fig. 3 I). After 120 min, control   
from the mitochondrial fraction (Fig. 2 D), but both 40- and   
60-kD OMA1 proteins were pelleted, showing that these are in-
tegral membrane proteins (Fig. 2 E). Dissipation of membrane 
potential with valinomycin and CCCP blocked import of Su9-
DHFR (Fig. 2 D), and it blocked the formation of the 40-kD 
OMA1 protein, but it did not prevent insertion of the 60-kD OMA1 
protein into mitochondrial membranes (Fig. 2 E). Oligomycin 
(an inhibitor of mitochondrial ATP synthase) and bongkrekic 
acid (an inhibitor of adenine nucleotide transporters) were used 
to  deplete  mitochondrial ATP.  Like  valinomycin  and  CCCP, 
these inhibitors blocked formation of the 40-kD OMA1 product 
but not insertion of 60-kD protein into mitochondrial membranes   
(Fig. 2 F). The amount of 40-kD protein in import reactions 
is low, perhaps because of high turnover or an abundance of 
unproductive translocation intermediates in the mitochondrial   
outer membrane. However, the formation of a trypsin-insensitive 
40-kD protein, which is inhibited by valinomycin/CCCP and 
by oligomycin/bongkrekic acid, showed that OMA1 protein 
is imported and correctly processed in isolated mitochondria, 
faithfully  recapitulating  the  results  obtained  with  transfected 
cells. Based on our in vivo and in vitro data, we propose that the 
OMA1 protease is itself controlled by proteolysis.
Effects of OMA1 siRNA on inducible 
cleavage of OPA1
OPA1 antibodies normally detect five bands on Western blots 
(labeled a–e; Griparic et al., 2007). Bands b and d are the most 
prominent. Band b contains isoforms that lack exons 4b or 5b 
and are therefore not constitutively cleaved. Band d consists of 
isoforms that are constitutively cleaved by YME1L in exons 4b 
or 5b (Griparic et al., 2007). Loss of membrane potential, low 
ATP, and apoptosis induce cleavage of isoforms that were not 
cleaved by YME1L, converting band b to band e. We tested 
whether OMA1 is responsible for this inducible cleavage by 
transfection  with  OMA1  siRNA  followed  by  treatment  with 
CCCP. Western blots show that the conversion of band b to band e 
was inhibited by 56% in these experiments (mean of five inde-
pendent experiments [SD = 12%]; as determined by densitome-
try of Western blots; Fig. 3 A). Similar results were obtained with 
three pairs of siRNA oligonucleotides targeting different re-
gions of the OMA1 mRNA. Inhibition of inducible cleavage 
was never observed with siRNA for other proteases (Griparic 
et al., 2007). There still is some inducible cleavage, even with 
90% reduction of OMA1 mRNA, so OMA1 may be partially 
redundant with other proteases or small amounts of residual 
OMA1 are enough for some cleavage of OPA1. Nevertheless, we 
can conclude that OMA1 siRNA inhibits inducible cleavage 
of OPA1.
Fig. 3 A shows reduced intensity of band e in cells trans-
fected with OMA1 siRNA even without CCCP treatment, sug-
gesting that a small fraction of protein in band e might result 
from constitutive cleavage by OMA1. However, the differences 
were not significant when the relative intensities of band e were 
compared in four different experiments (Fig. S1 A). It would 
appear that inducible proteolysis of OPA1 is exquisitely sensi-
tive to slight disruptions in the overall conditions of cells, 
particularly at the time of harvest. OMA1 siRNA also had no 963 Inducible cleavage of OPA1 by OMA1 • Head et al.
Effects of OMA1 siRNA on apoptosis
It was shown previously that OPA1 is cleaved concurrent 
with cytochrome c release during apoptosis (Duvezin-Caubet   
et al., 2006; Baricault et al., 2007; Griparic et al., 2007). In 
this study, we show that OMA1 siRNA slowed the onset of 
cells also regained tubular morphologies through de novo syn-
thesis of OPA1 protein, as shown previously with cycloheximide 
(Griparic et al., 2007). We conclude that mitochondria of OMA1 
siRNA cells fuse under conditions that would normally prevent 
fusion because of proteolytic inactivation of OPA1.
Figure  3.  Effects  of  OMA1  on  CCCP-induced 
cleavage  of  OPA1  and  recovery  of  fusion  com-
petence after CCCP washout. (A) HeLa cells were 
transfected  with  OMA1  siRNA  or  scrambled 
oligonucleotides followed by 30 min with 10 µM   
CCCP  (OMA1  RNA  was  reduced  by  90%). 
CCCP-induced cleavage normally converts band 
b  to  band  e,  but  this  cleavage  is  inhibited  by 
OMA1 siRNA (arrow). (B) Effects of Oma1 siRNA 
on  CCCP-induced  cleavage  are  suppressed  by 
cotransfected  wild-type  OMA1  but  not  by  the 
OMA1(H331A) mutant. Cotransfected OPA1 iso-
form 1 was detected with an myc tag (Griparic et al., 
2007). Isoform 1 is not cleaved by YME1L, but it 
is cleaved by OMA1, showing a CCCP-induced 
shift from band b to band e. OMA1 expression 
and the shift from 40- to 60-kD proteins are shown 
on the bottom. Black lines indicate that interven-
ing lanes have been spliced out. (C–I) Effects of 
OMA1  siRNA  on  recovery  from  CCCP-induced 
mitochondrial  fragmentation.  HeLa  cells  were 
transfected with scrambled (C–E) or OMA1 siRNA 
(F–H).  Mitochondria  are  normally  filamentous   
(C and F) but fragment after 30 min with CCCP 
(D and G). At 90 min after CCCP washout, the 
filamentous  morphology  of  mitochondria  returns 
more quickly in OMA1 siRNA cells (H) than in 
control cells (E). (I) Percentages of cells with fully 
fragmented mitochondria (open bars) or with par-
tial or full recovery of tubular mitochondria (closed 
bars) are shown at 60 or 90 min after washout. 
Means and SD were determined with six plates 
in  two  independent  experiments  (400  cells  per 
plate). P-values were determined with an unpaired 
Student’s t test. OMA1 expression was reduced by 
70% (means with real-time PCR). Bar, 10 µm.JCB • VOLUME 187 • NUMBER 7 • 2009   964
OMA1 siRNA and by the rescue of inducible proteolysis with   
cotransfected wild-type OMA1 but not with mutant OMA1. 
Inducible proteolysis was never inhibited by knockdown of other 
mitochondrial proteases (Griparic et al., 2007), nor did OMA1 
siRNA affect constitutive proteolysis of OPA1. Functional 
evidence for the inhibitory effects on proteolytic inactivation 
of OPA1 is provided by CCCP washout experiments in which 
we showed that cells transfected with OMA1 siRNA recovered 
fused mitochondria more quickly than mock-transfected cells 
and with apoptosis experiments in which we showed that OMA1 
siRNA inhibited apoptosis. Cleavage of OPA1 by OMA1, as 
described in this study, and constitutive proteolysis by YME1L, 
as described previously (Griparic et al., 2007; Song et al., 2007; 
Guillery et al., 2008), account for the banding patterns of OPA1 
on Western blots.
Our results also suggest a mechanism for the control of 
OMA1 activity. Transfections with OMA1 expression constructs 
show a dominant 40-kD cleavage product of OMA1 in untreated 
cells. The amount of 40-kD protein is reduced in cells treated with 
CCCP, suggesting that this protein is subjected to further proteo-
lytic degradation. However, CCCP also leads to the accumulation 
of uncleaved OMA1. Because this accumulation coincides with 
OMA1 cleavage of OPA1, we propose that the 60-kD band is the 
active species and the 40-kD band is a breakdown product. These 
observations lead to a model in which OMA1 activity is normally 
attenuated by high rates of turnover. This turnover is slowed when 
mitochondria lose membrane potential or matrix ATP, making it 
possible to cleave the OPA1 protein (Fig. 5).
Rapid proteolytic inactivation of OPA1 may have co-
evolved with other inducible processes such as cytochrome c 
staurosporine-induced cleavage of OPA1 (Fig. 4 A), indicating 
that apoptosis and CCCP induce cleavage through the same 
mechanism. Loss of DRP1 also inhibits apoptosis (Frank et al., 
2001), but it did not inhibit induced cleavage of OPA1 (Fig. 4 A). 
The effects of DRP1 and OPA1 on apoptosis may be independent;   
DRP1 contributes to mitochondrial outer membrane perme-
abilization (Cassidy-Stone et al., 2008), whereas OPA1 may   
affect cytochrome c release from within cristae (Duvezin-Caubet   
et al., 2006).
We could now also test whether OPA1 cleavage actively 
promotes apoptosis. To this end, HeLa cells were transfected 
with OMA1 siRNA, followed by treatment with staurosporine 
and counting the numbers of cells with pyknotic nuclei. The 
percentages of pyknotic nuclei were significantly lower in cells 
transfected with OMA1 siRNA than in control cells up to 3 h 
after treatment with staurosporine (Fig. 4 B). At longer time 
points, all cells had pyknotic nuclei, showing that the inhibition 
of apoptosis is not absolute (unpublished data). Similar effects 
were observed with cytochrome c release induced by actino-
mycin D (Fig. S3). We conclude that OMA1 siRNA inhibits 
apoptotic release of cytochrome c and further progression of 
apoptosis similar to the inhibitory effects of Drp1 and Fis1 siRNA, 
but these effects are not complete, perhaps because knockdown 
of OMA1 was incomplete or because apoptosis does not abso-
lutely require loss of OPA1 function.
Conclusions
Our results show that OMA1 is responsible for CCCP-induced 
cleavage of OPA1 in mammalian cells. Evidence for this role is 
provided by the specific inhibition of inducible proteolysis with 
Figure 4.  Effects of OMA1 siRNA on apoptosis. (A) HeLa 
cells  were  transfected  with  siRNA  oligonucleotides  fol-
lowed by 0, 3, and 6 h with staurosporine (STS). Extracts 
were blotted and probed with OPA1 antibody. Staurospo-
rine converts band b to band e, similar to CCCP-induced 
cleavage.  OMA1  siRNA  slows  this  process,  whereas 
DRP1 siRNA does not, even though DRP1 siRNA inhibits 
apoptosis (detected with PARP and caspase cleavage; not   
depicted). The black line indicates that intervening lanes 
have been spliced out. (B) The effects of OMA1 siRNA on   
staurosporine-induced  apoptosis  were  determined  by 
counting the numbers of pyknotic nuclei in 300 cells for 
each time point. Mean values for three independent experi-
ments are given with SD. The significance of differences 
between scrambled (closed bars) and OMA1 siRNA (open 
bars) was determined with an unpaired Student’s t test.965 Inducible cleavage of OPA1 by OMA1 • Head et al.
Hamamatsu Photonics) controlled by Axiovision software (Carl Zeiss, Inc.). 
Image files were processed with Photoshop software (Adobe). Membrane 
potential was disrupted with 10 µM CCCP (Sigma-Aldrich). In washout ex-
periments, cells were rinsed twice with PBS and incubated with fresh me-
dium. Controls were treated with solvent (DMSO). Apoptosis was induced 
with 2 µM staurosporine (Sigma-Aldrich) or 20 µM actinomycin D (EMD) 
with 200 µM zVAD-fmk (MP Biomedicals) added 30 min before actino-
mycin D. Pyknotic nuclei were counted by staining with Hoechst (Gandre-
Babbe and van der Bliek, 2008). Cells were lysed in Laemmli sample 
buffer. Blots were probed with OPA1 and calnexin (BD), HA (Roche), CoxI 
(MitoSciences), tubulin (Sigma-Aldrich), and c-myc (AbD Serotec) anti-
bodies. Blots were developed with horseradish peroxidase secondary anti-
body and chemiluminescence (GE Healthcare). Subcellular fractions were 
isolated by differential centrifugation (Gandre-Babbe and van der Bliek, 
2008).  For  densitometry,  film  was  scanned  with  a  phosphorimager   
(Typhoon 9410; GE Healthcare) and analyzed with ImageQuant software 
(GE Healthcare).
Plasmids, siRNA oligonucleotides, and transfection techniques
OMA1 cDNA was modified using PCR to add two C-terminal HA tags in 
pCMV-SPORT6  (Invitrogen).  OMA1(H331A)  was  made  by  site-directed 
mutagenesis. OPA1 isoforms were cloned in pCDNA3.1 with a C-terminal 
myc tag (Griparic et al., 2007). Su9-DHFR plasmid was a gift from C. Koehler 
(University of California, Los Angeles, Los Angeles, CA). Oligonucleo-
tides for siRNA were synthesized by Sigma-Aldrich. OMA1 sequences 
were  5-GGCUGGCAUGGUUCAUUUGdTdT-3  (first),  5-CCGAUAUU-
CAUCAACUUUCdTdT-3  (second),  and  5-GAAGUGCUUUGUCAUCU-
AAdTdT-3 (third). Most experiments were performed with the third set, but 
effects on OPA1 cleavage were confirmed with the first two pairs as well. 
Scrambled controls had inverted sequences. HeLa cells were transfected 
with 60 pmol siRNA and Fugene6 HD (Roche). Cells were split on day 2 
release from mitochondria during apoptosis. Alternatively, 
rapid proteolytic inactivation of OPA1 might help eliminate 
defective fragments of mitochondria because those fragments 
lose membrane potential and will thus lose their ability to re-
fuse with other mitochondria (Twig et al., 2008). Both of these 
scenarios suggest that OMA1-mediated cleavage of OPA1 is 
beneficial  for  growth  and  development.  However,  inducible 
proteolysis could also have pathogenic effects in neurodegen-
erative  diseases  such  as  Parkinson’s  (Yang  et  al.,  2008)  or 
DOA. Identification of OMA1 as the protease responsible for 
inducible cleavage of OPA1 may lead to selective inhibitors, 
which could help reduce the debilitating effects of these neuro-
degenerative diseases.
Materials and methods
Cell culture, protein analysis, and microscopy
For the experiments in Fig. 1, HeLa cells were stained with MitoTracker red 
CMXRos (Invitrogen), fixed with formaldehyde, and processed for antibody 
staining and detection with FITC (Griparic et al., 2007). For the experi-
ments in Fig. 3 and Fig. S2, mitochondria were detected by transfection 
with mitochondrial DsRed2 (Takara Bio Inc.). Fluorescence microscopy was 
performed with a microscope (Axiovert 200M; Carl Zeiss, Inc.) using a 
Plan-NeoFluar 40× NA 1.3 oil objective (Fig. S2) or an  Plan-Fluar 100× 
NA 1.45 oil objective (all other figures). Images were acquired at room 
temperature  (24°C)  with  a  charge-coupled  device  camera  (ORCA  ER; 
Figure 5.  Pathways for proteolytic processing of OPA1. (A) The constitutive cleavage pathway. All isoforms of OPA1 have a mitochondrial leader se-
quence, which is constitutively cleaved by the matrix protease mitochondrial processing peptidase (MPP). Some isoforms contain exon 4b, which has a 
cleavage site that we name S3, and some isoforms have exon 5b, which has a cleavage site named S2 (Ishihara et al., 2006). Isoforms with exon 4b 
or 5b are constitutively cleaved by YME1L to produce S-OPA1. Isoforms lacking exons 4b and 5b are not cleaved by YME1L, thus producing L-OPA1. 
Mitochondrial fusion requires a mixture of S- and L-OPA1. (B) The pathway for inducible cleavage. L-OPA1, which is not cleaved by YME1L, remains sus-
ceptible to inducible cleavage in the S1 site of exon 5 by OMA1. This inducible cleavage occurs when mitochondria lose membrane potential or ATP. Loss 
of membrane potential also leads to an accumulation of 60-kD OMA1 and reduced amounts of 40-kD OMA1, suggesting that OMA1 activity is regulated 
by OMA1 turnover. Another, as of yet unknown, protease may attenuate OMA1 activity by proteolytic degradation. This attenuation is slowed when mito-
chondria lose membrane potential or ATP, thus allowing for cleavage of OPA1. Alternatively, membrane potential or ATP levels may also directly affect 
OMA1 activity. IMS, intermembrane space; PD, protease domain.JCB • VOLUME 187 • NUMBER 7 • 2009   966
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and transfected again on day 3. On day 4, cells were stained for micros-
copy or harvested for RNA and protein analysis. RNA was quantified in 
triplicate with real-time PCR (Griparic et al., 2007). For CCCP recovery ex-
periments  and  OMA1  overexpression,  cells  were  cotransfected  with 
MitoDsRed (Takara Bio Inc.).
Import of proteins into isolated mitochondria
OMA1  and  Su9-DHFR  proteins  were  synthesized  with  [
35S]methionine 
(PerkinElmer) and TNT SP6-coupled reticulocyte lysates (Promega). Mito-
chondria  were  isolated  from  mouse  liver  (provided  by  C.  Koehler)  by 
homogenization and differential centrifugation. Mitochondria were resus-
pended at 2 mg protein/ml in 250 mM sucrose, 5 mM MgAc, 100 mM 
KAc, 10 mM Na-succinate, and 20 mM Hepes/KOH, pH 7.4, adding   
2.5 mM ATP, 0.1 mM ADP, 1 mM DTT, and 10 mM methionine before 
starting reactions with in vitro–synthesized protein. Reactions were stopped 
with 1 µM valinomycin and 20 µM CCCP. Where indicated, 5 µM oligo-
mycin  and  50  µM  bongkrekic  acid  were  added  before  the  reaction. 
Where indicated, samples were incubated on ice with 100 µg/ml tryp-
sin (Sigma-Aldrich) for 20 min, followed with 200 µg/ml trypsin inhibitor 
(Sigma-Aldrich). 2 vol of 0.6 M sorbitol, 50 mM Hepes/KOH, pH 7.4, 
and 80 mM KCl were added, and mitochondria were pelleted by centrifu-
gation. Untreated and trypsinized samples were dissolved in Laemmli sam-
ple buffer. Remaining samples were subjected to alkaline extraction with   
30 min on ice in 0.2 M Na2CO3/NaOH, pH 12. Membranes were pel-
leted for 30 min at 21,000 g. Proteins in supernatants were precipitated 
with trichloroacetic acid. Carbonate and trichloroacetic acid pellets were 
resuspended in Laemmli sample buffer and size fractionated by SDS-PAGE. 
Gels were dried and analyzed with a Typhoon 9410 phosphorimager.
Online supplemental material
Fig. S1 shows that OMA1 does not affect constitutive proteolysis of OPA1. 
Fig. S2 shows the effects of OMA1 expression and siRNA on mitochon-
drial morphology. Fig. S3 shows the effects of OMA1 siRNA on actino-
mycin D–induced apoptosis. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200906083/DC1.
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